Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline

Por Sturm, Stefan, Forsberg, Anton, Nave, Stephane, Stenkrona, Per, Seneca, Nicholas, Varrone, Andrea, Comley, Robert A., Fazio, Patrik, Jamois, Candice, Nakao, Ryuji, Ejduk, Zbigniew, Al-Tawil, Nabil, Akenine, Ulrika, Halldin, Christer, Andreasen, Niels, Ricci, Benedicte
Publicado no Eur J Nucl Med Mol Imaging (2016)

Sembragiline in Moderate Alzheimer’s Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD)

Por Nave, Stephane, Doody, Rachelle S., Boada, Mercè, Grimmer, Timo, Savola, Juha-Matti, Delmar, Paul, Pauly-Evers, Meike, Nikolcheva, Tania, Czech, Christian, Borroni, Edilio, Ricci, Benedicte, Dukart, Juergen, Mannino, Marie, Carey, Tracie, Moran, Emma, Gilaberte, Inma, Muelhardt, Nicoletta Milani, Gerlach, Irene, Santarelli, Luca, Ostrowitzki, Susanne, Fontoura, Paulo
Publicado no J Alzheimers Dis (2017)